Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Canagliflozin-loaded magnetic nanoparticles as potential treatment of hypoxic tumors in combination with radiotherapy.
Angelopoulou A, Kolokithas-Ntoukas A, Papaioannou L, Kakazanis Z, Khoury N, Zoumpourlis V, Papatheodorou S, Kardamakis D, Bakandritsos A, Hatziantoniou S, Avgoustakis K. Angelopoulou A, et al. Among authors: zoumpourlis v. Nanomedicine (Lond). 2018 Oct;13(19):2435-2454. doi: 10.2217/nnm-2018-0145. Epub 2018 Oct 12. Nanomedicine (Lond). 2018. PMID: 30311542
Design and Synthesis of Novel 2-Acetamido, 6-Carboxamide Substituted Benzothiazoles as Potential BRAFV600E Inhibitors - In vitro Evaluation of their Antiproliferative Activity.
Batsi Y, Antonopoulou G, Fotopoulou T, Koumaki K, Kritsi E, Potamitis C, Goulielmaki M, Skarmalioraki S, Papalouka C, Poulou-Sidiropoulou E, Kosmidou V, Douna S, Vidali MS, Gkotsi EF, Chatziioannou A, Souliotis VL, Pletsa V, Papadodima O, Zoumpourlis V, Georgiadis P, Zervou M, Pintzas A, Kostas ID. Batsi Y, et al. Among authors: zoumpourlis v. ChemMedChem. 2023 Nov 16;18(22):e202300322. doi: 10.1002/cmdc.202300322. Epub 2023 Oct 24. ChemMedChem. 2023. PMID: 37792577
N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor.
Logotheti S, Khoury N, Vlahopoulos SA, Skourti E, Papaevangeliou D, Liloglou T, Gorgoulis V, Budunova I, Kyriakopoulos AM, Zoumpourlis V. Logotheti S, et al. Among authors: zoumpourlis v. Transl Res. 2016 Jul;173:58-73.e2. doi: 10.1016/j.trsl.2016.03.009. Epub 2016 Mar 21. Transl Res. 2016. PMID: 27063960
Synthesis, characterization and in vivo evaluation of a magnetic cisplatin delivery nanosystem based on PMAA-graft-PEG copolymers.
Voulgari E, Bakandritsos A, Galtsidis S, Zoumpourlis V, Burke BP, Clemente GS, Cawthorne C, Archibald SJ, Tuček J, Zbořil R, Kantarelou V, Karydas AG, Avgoustakis K. Voulgari E, et al. Among authors: zoumpourlis v. J Control Release. 2016 Dec 10;243:342-356. doi: 10.1016/j.jconrel.2016.10.021. Epub 2016 Oct 26. J Control Release. 2016. PMID: 27793687
A Triphenylphosphonium-Functionalized Mitochondriotropic Nanocarrier for Efficient Co-Delivery of Doxorubicin and Chloroquine and Enhanced Antineoplastic Activity.
Panagiotaki KN, Sideratou Z, Vlahopoulos SA, Paravatou-Petsotas M, Zachariadis M, Khoury N, Zoumpourlis V, Tsiourvas D. Panagiotaki KN, et al. Among authors: zoumpourlis v. Pharmaceuticals (Basel). 2017 Nov 21;10(4):91. doi: 10.3390/ph10040091. Pharmaceuticals (Basel). 2017. PMID: 29160846 Free PMC article.
KLK6 protease accelerates skin tumor formation and progression.
Khoury N, Zingkou E, Pampalakis G, Sofopoulos M, Zoumpourlis V, Sotiropoulou G. Khoury N, et al. Among authors: zoumpourlis v. Carcinogenesis. 2018 Dec 31;39(12):1529-1536. doi: 10.1093/carcin/bgy110. Carcinogenesis. 2018. PMID: 30137206
Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights.
Cheimonidi C, Samara P, Polychronopoulos P, Tsakiri EN, Nikou T, Myrianthopoulos V, Sakellaropoulos T, Zoumpourlis V, Mikros E, Papassideri I, Argyropoulou A, Halabalaki M, Alexopoulos LG, Skaltsounis AL, Tsitsilonis OE, Aligiannis NN, Trougakos IP. Cheimonidi C, et al. Among authors: zoumpourlis v. Redox Biol. 2018 Jun;16:169-178. doi: 10.1016/j.redox.2018.02.015. Epub 2018 Mar 1. Redox Biol. 2018. PMID: 29505920 Free PMC article.
Functions, divergence and clinical value of TAp73 isoforms in cancer.
Logotheti S, Pavlopoulou A, Galtsidis S, Vojtesek B, Zoumpourlis V. Logotheti S, et al. Among authors: zoumpourlis v. Cancer Metastasis Rev. 2013 Dec;32(3-4):511-34. doi: 10.1007/s10555-013-9424-x. Cancer Metastasis Rev. 2013. PMID: 23592418 Review.
125 results